SRINIVAS AKKARAJU - 22 May 2025 Form 4 Insider Report for Scholar Rock Holding Corp (SRRK)

Role: Director
Signature: /s/ Junlin Ho, Attorney-in-Fact for Srinivas Akkaraju
Issuer symbol: SRRK
Transactions as of: 22 May 2025
Net transactions value: $0
Form type: 4
Filing time: 23 May 2025, 16:44:05 UTC
Previous filing: 23 May 2025
Next filing: 12 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
AKKARAJU SRINIVAS	Director	301 BINNEY STREET, CAMBRIDGE	/s/ Junlin Ho, Attorney-in-Fact for Srinivas Akkaraju	23 May 2025	0001253170

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRRK	Common Stock	Award	$0	+7,632	+57%	$0.000000	21,132	22 May 2025	Direct	F1, F2
holding	SRRK	Common Stock						5,612,896	22 May 2025	By Samsara BioCapital, L.P.	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRRK	Stock Option (Right to Buy)	Award	$0	+9,206		$0.000000	9,206	22 May 2025	Common Stock	9,206	$30.46	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2026 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.
F2	Consists of 13,500 shares of Common Stock and 7,632 RSUs.
F3	Shares held by Samsara BioCapital LP ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F4	Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date.